Novavax, Inc. (NVAX)
9.235
-0.12
(-1.34%)
USD |
NASDAQ |
May 07, 16:00
9.32
+0.08
(+0.92%)
After-Hours: 07:09
Novavax Total Liabilities (Quarterly) : 1.188B for March 31, 2026
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Merck & Co., Inc. | 82.75B |
| Pfizer Inc. | 117.21B |
| Moderna, Inc. | 4.08B |
| Johnson & Johnson | 119.71B |
| Intellia Therapeutics, Inc. | 170.73M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 1.043B |
| Shareholders Equity (Quarterly) | -144.76M |
| Debt to Equity Ratio | -2.038 |
| Current Ratio | 2.484 |
| Net Debt Paydown Yield | -0.48% |